Search research articles
联系我们
Search research articles
Search
相关实验视频
利巴维林 (Ribavirin) 是一种药物.
M E Noble
Lancet (London, England)
|
December 12, 1987
中文
概括
No abstract available in
PubMed
.
相关概念视频
您也可能阅读
相关文章
通过共同作者、期刊和引用图与本文相关的文章。
排序
全部
12
Same author
6
Same journal
6
Same author
Xenopus phospho-CDK7/cyclin H expressed in baculoviral-infected insect cells.
Protein expression and purification
·
2001
Same author
Phosphoprotein-protein interactions revealed by the crystal structure of kinase-associated phosphatase in complex with phosphoCDK2.
Molecular cell
·
2001
Same author
Inhibitor binding to active and inactive CDK2: the crystal structure of CDK2-cyclin A/indirubin-5-sulphonate.
Structure (London, England : 1993)
·
2001
Same author
The role of the Src homology 3-Src homology 2 interface in the regulation of Src kinases.
The Journal of biological chemistry
·
2001
Same author
Identification of novel purine and pyrimidine cyclin-dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profiles.
Journal of medicinal chemistry
·
2000
Same author
Structure of arylamine N-acetyltransferase reveals a catalytic triad.
Nature structural biology
·
2000
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)
·
2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)
·
2026
Same journal
Research priorities for characterising Bundibugyo virus.
Lancet (London, England)
·
2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)
·
2026
Same journal
Dual mobility total hip replacement in fractures: stability promotes patient confidence.
Lancet (London, England)
·
2026
Same journal
Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.
Lancet (London, England)
·
2026
查看所有相关文章